B Sundberg
Overview
Explore the profile of B Sundberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gaballa A, Norberg A, Stikvoort A, Mattsson J, Sundberg B, Uzunel M, et al.
Bone Marrow Transplant
. 2017 Oct;
53(1):69-77.
PMID: 28991250
Reconstitution of the adaptive immune system following allogeneic hematopoietic stem cell transplantation is crucial for beneficial outcome and is affected by several factors, such as GvHD and graft source. The...
2.
Radestad E, Wikell H, Engstrom M, Watz E, Sundberg B, Thunberg S, et al.
J Immunol Res
. 2014 Nov;
2014:578741.
PMID: 25371909
Allogeneic hematopoietic stem cell transplantation is associated with several complications and risk factors, for example, graft versus host disease (GVHD), viral infections, relapse, and graft rejection. While high levels of...
3.
Mougiakakos D, Jitschin R, von Bahr L, Poschke I, Gary R, Sundberg B, et al.
Leukemia
. 2012 Jul;
27(2):377-88.
PMID: 22828446
Myeloid-derived suppressor cells (MDSCs) have emerged as a heterogeneic immunoregulatory population that can expand in response to inflammatory signals. Predominantly studied in cancer, MDSCs suppress T cells utilizing various mechanisms....
4.
von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B, et al.
Stem Cells
. 2012 May;
30(7):1575-8.
PMID: 22553154
Mesenchymal stromal cells (MSCs) are explored as a novel treatment for a variety of medical conditions. Their fate after infusion is unclear, and long-term safety regarding malignant transformation and ectopic...
5.
Sundin M, Remberger M, Lonnies H, Sundberg B, Ringden O, Le Blanc K
Cytotherapy
. 2008 Apr;
10(3):238-42.
PMID: 18418769
Background: Multipotent mesenchymal stromal cells (MSC) are candidates for cellular therapy in regenerative medicine and as treatment of graft-versus-host-disease (GvHD) after hematopoietic stem cell (HSC) transplantation. It has been suggested...
6.
Ringden O, Uzunel M, Sundberg B, Lonnies L, Nava S, Gustafsson J, et al.
Leukemia
. 2007 Jul;
21(11):2271-6.
PMID: 17611560
Mesenchymal stem cells (MSC) possess anti-inflammatory properties and participate in tissue repair. We used MSC to heal therapy-induced tissue toxicity. Ten consecutive patients, treated with MSC due to tissue toxicity...
7.
Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, et al.
Leukemia
. 2007 Jun;
21(8):1733-8.
PMID: 17541394
Seven patients underwent treatment with mesenchymal stem cells (MSCs), together with allogeneic hematopoietic stem cell transplantation (HSCT). MSCs were given to three patients for graft failure and four patients were...
8.
Rasmusson I, Le Blanc K, Sundberg B, Ringden O
Scand J Immunol
. 2007 Mar;
65(4):336-43.
PMID: 17386024
Mesenchymal stem cells (MSC) have immunomodulatory effects and inhibit T-cell responses to alloantigens and mitogens in vitro and in vivo. We wanted to examine the effect of MSC on human...
9.
Sundin M, Orvell C, Rasmusson I, Sundberg B, Ringden O, Le Blanc K
Bone Marrow Transplant
. 2006 Apr;
37(11):1051-9.
PMID: 16604097
Allogeneic stem cell transplantation is often complicated by reactivation of herpesviruses. Mesenchymal stem cells (MSC) are immunomodulatory and may be used to treat graft-versus-host disease. We investigated if herpesviruses infect...
10.
Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, et al.
Scand J Immunol
. 2004 Aug;
60(3):307-15.
PMID: 15320889
Mesenchymal stem cells (MSC) are immunomodulatory and inhibit lymphocyte proliferation. We studied surface expression of lymphocyte activation markers and secreted cytokines, when lymphocytes were activated in the presence of MSC....